A trusted partner in clinical research and development.
Clinical Research, Backed by Expertise.
Ordoclin supports pharmaceutical, biotech, generic drug, and medical device companies through integrated clinical research operations spanning Phase I clinical trials, Bioavailability & Bioequivalence (BA/BE) studies, and Medical Device clinical trials. With more than 21 years of experience in regulated research environments, our operations are structured around scientific oversight, regulatory compliance, and consistent study execution across global clinical development programs.
Our clinical, bioanalytical, biometrics, and regulatory teams operate within a connected workflow framework designed to support submission-ready research programs aligned with FDA, EMA, MHRA, TGA, CDSCO, and EU MDR expectations. Supported by dedicated Phase I infrastructure, GLP-compliant bioanalytical laboratories, specialized inhalation study capability, and digital clinical systems, our research environments are built to support complex studies requiring operational control, data integrity, and regulatory-focused execution.
The standards we work by.
Advancing regulated clinical research through scientifically driven study execution, operational accountability, and ethically conducted research programs designed to support the development of safe, effective, and globally accepted therapies and medical technologies.
Building a globally recognized clinical research environment driven by scientific rigor, regulatory trust, and operational excellence — supporting the advancement of pharmaceutical, biotech, and medical device development programs across evolving global healthcare markets.
Driven by scientific integrity, operational accountability, and regulatory discipline, our research environments are built to support compliant study execution, reliable data quality, and responsible clinical research across globally regulated development programs.
Clinical & Bioanalytical Operations Under One Roof
Our Vadodara facility supports Phase I clinical trials and specialized early-phase studies through monitored clinical infrastructure, ICU-level safety oversight, and controlled research environments designed for complex clinical programs.
The Chennai facility supports BA/BE studies and integrated bioanalytical operations through GLP-compliant laboratory systems, PK processing workflows, and dedicated analytical infrastructure supporting regulated clinical development programs.
Supporting global clinical programs through structured research operations.
Ordoclin brings experienced teams with specialized expertise in handling complex products and clinical research requirements across pharmaceutical, biotech, generic drug, and medical device programs. From study design and scientific strategy to protocol development, scientific correspondence, and operational planning, our teams build structured approaches tailored to the requirements of each complex study.
We work closely with partners throughout study execution, combining scientific oversight, regulatory coordination, and operational expertise to address challenges and maintain study quality at every stage. Our integrated approach is designed to support successful study outcomes, strengthen regulatory submissions, and help partners progress complex clinical programs toward approval and development success
